Alopecia in Cancer Patients and Survivors

The presentation focuses on the impact of alopecia in cancer patients and survivors, highlighting that nearly half of diagnosed patients experience significant hair loss, which is often deemed the most traumatic side effect of cancer treatment. Alopecia affects quality of life, with some patients reportedly refusing chemotherapy due to fear of hair loss. The talk discusses the mechanisms behind chemotherapy-induced hair loss and reviews the efficacy of scalp cooling devices, which can help retain hair during treatment, with over 60% of users retaining significant hair coverage. However, these devices come with discomfort and potential side effects such as frostbite. Additionally, studies show that a considerable percentage of women undergoing chemotherapy do not fully regrow their hair, leading to distress and altered appearances. Various treatment options like low-dose minoxidil and PRP therapy are explored as potential remedies for post-chemotherapy alopecia. Evidence suggests a combination of interventions could enhance outcomes for patients, emphasizing the need for better awareness and involvement of dermatologists in the care of cancer survivors to address the psychological and aesthetic effects of hair loss.